Exhibit 10.60


CONSULTING
AGREEMENT


 


This agreement
(the "Agreement") is being made and entered into as of March 21, 2013 (the “Agreement”) by
and between InterCure Ltd, an Israeli publicly traded company, with its principal offices at 16 Hatidhar St. P.O. Box 4131
Raanana, 43665, Israel, Israel (the "Company") and Prof. Reuven Zimlichman, I.D. number 60592334
of 53 David Hamelech Str. Herzlia, 46661Herzliya (the “Consultant”). Each of the Company and Consultant
shall be referred to as a "Party", and collectively the "Parties".


 


WHEREAS,
The Company is engaged in the business of manufacturing and marketing products and services in the field of medical devices based
on a proprietary technology of rhythmical biological modulation (the "Field")


 


WHEREAS, the
Consultant has the necessary know-how, qualifications and experience in the Field required in order to provide the Services (as
defined below);


 


WHEREAS, the
Company desires to appoint the Consultant as the Company's Medical Director, and the Consultant desires to be so appointed by the
Company and to provide to the Company with consulting services, as detailed in Schedule A attached hereto to this
Agreement (the "Services");


 


NOW THEREFORE, in consideration
of the mutual undertakings and promises herein contained, the parties hereby agree as follows:


 


		1	THE SERVICES



 


		1.1	During the Term of Agreement (as defined below), the Consultant shall provide the Company with
consulting services as set out in Schedule A attached hereto (the “Consulting Services”), all
subject to and in accordance with the terms and conditions set forth in this Agreement.



 


		1.2	The Consultant undertakes that: (i) the Services shall be performed in a professional and workmanlike
manner consistent with applicable standards for the performance of the same or similar services; (ii) the necessary resources shall
be devoted to the performance of the Services; and (iii) that in the rendering of the Services, the Consultant will not make use
of any confidential or proprietary information belonging to any third party and shall avoid operating and/or performing any Services
in a manner which infringes or is likely to infringe the rights of any third party




 


		1.3	The Consultant shall provide the Services under the supervision of the Chief Executive Officer
of the Company, or any such person designated by the Chief Executive Officer of the Company at his sole discretion (the Chief Executive
Officer of the Company or the said designated person: the "Designee").



 


		1.4	Consultant will devote up to 20 hours each month to the rendering of the Services, as shall be
requested by the Company.



 


		1.5	During the Term of Agreement (as defined below) the Consultant shall keep the Company, through
the Designee, or such person designated by the Designee, currently informed as to his activities hereunder and shall, each month
or upon the request of the Company, provide the Company with written itemized reports detailing the rendered Services.



 




    	 



    	 



    

 


		1.6	Without derogating from any other provision of this Agreement, the Consultant acknowledges and
agrees that the Company retain the Consultant on a non-exclusive basis, and that the Company is entitled, at its own and absolute
discretion and at any time, to appoint other consultants, agents or employees to perform the Services.



 


		2	COMPENSATION



 


		2.1	In consideration for the rendered Services, the Company shall compensate the Consultant as follows:



 


		2.1.1	The Consultant shall be entitled to a monthly consulting fee of US$ 1,500 (one thousand five hundred
US Dollars) (the "Consulting Fee"). Such fee shall not include VAT, which shall be added, in accordance with applicable
law, to each payment of the Consulting Fee.



 


		2.1.2	Subject to the approval of the Company's Board of Directors and any approvals required by applicable
law, the Company shall grant to the Consultant 130,000 options exercisable to 130,000 ordinary shares of the Company with no par
value each, under the Company’s ESOP (as defined below) (the “Options") subject to the following conditions:



 


		(1)	The Options shall vest over three
(3) years in 12 equal quarterly installments (commencing on the date of the grant of the Options).



 


		(2)	The Options shall be granted in accordance with the provisions of the Company’s ESOP and
under Section 102 of the Income Tax Ordinance, 1961. If applicable



 


		(3)	The exercise price of each Option shall be NIS 0.54



 


		(3)	The Options shall be granted in accordance with the provisions of a grant letter to be signed between
the Consultant and the Company and shall be at all times subject to the terms of the Company's Employee Share Option Plan (“ESOP”).



 


		(4)	Any tax liability in connection with the Options (including with respect to the grant, exercise,
sell of the Option or the shares receivable upon their exercise) shall be borne solely by the Consultant.



 


		(5)	Upon the closing of transaction between the Company and
one of Israel`s medical institutions such as Sick Funds (Kupat Holim), hospitals, clinic etc. resulting in the sale of one of
the Company`s products through such institution of over US$ 175,000), thirty percent (30%) of all the unvested Options at the
time of the closing of such transaction shall immediately vest and be exercisable by the Consultant.



 


		2.2	In addition to the grant of Options, consultant shall be entitled to receive a one-time bonus in
the event of one of the following:



 


		(1)	Upon a closing of a transaction (lead by the consultant) between the Company and one of Israel`s
medical institution such as Sick Funds (Kupat Holim), hospitals, clinic etc., resulting in the sale of one of the Company`s products
through such institution of over US$ 100,000 a one-time bonus shall be paid to Consultant in the sum equal to US$ 4,000.



 




    	 



    	 



    

 


		(2)	Upon a closing of a transaction (lead by the consultant) between the Company and one of Israel`s
medical institution such as Sick Funds (Kupat Holim), hospitals, clinic etc., resulting in the sale of one of the Company`s products
through such institution of over US$ 200,000 a one-time bonus shall be paid to Consultant in the sum equal to US$ 10,000.



 


		(3)	Upon a closing of a transaction (lead by the consultant) between the Company and one of Israel`s
medical institution such as Sick Funds (Kupat Holim), hospitals, clinic etc., resulting in the sale of one of the Company`s products
through such institution of over US$ 300,000) a one-time bonus shall be paid to Consultant in the sum equal to US$ 15,000



 


		(4)	Upon the publication of no less than two articles authored by the Consultant focusing on the Company
and its technology and products in a leading medical journal in US or the EU, a one-time bonus shall be paid to Consultant in the
sum equal to US$ 4,000. Without derogating from the aforesaid, such bonus shall be subject to the approval of the Board of Directors
of the Company, and any other approvals required in accordance to applicable law.



 


		(5)	Upon the successful completion of a clinical trial conducted by the Company in connection with
a product of the Company, supervised, designed and directed by the Consultant, a one-time bonus shall be paid to Consultant in
the sum equal to US$ 8,000. Without derogating from the aforesaid, such bonus shall be subject to the approval of the Board of
Directors of the Company, and any other approvals required in accordance to applicable law.



 


		2.3	The Company shall pay the Consulting Fee against a monthly invoice provided by Consultant to the
Company. The Consulting Fee shall be paid to Consultant within a period of 30 days commencing on the end of the calendar month
of which the Service were rendered.



 


		2.4	In addition to the Consulting Fee, the Company shall reimburse the Consultant for any reasonable
expenses incurred by Consultant, which are to be approved in advance by the Company, including transportation expenses in Israel
and abroad (the "Approved Expenses"). Consultant shall submit, in writing, in the proper format as defined
by the Company from time to time, an expense report in connection with the Approved Expenses, to which written receipts and/or
invoices evidencing such expenses shall be attached. Where expenses have been incurred by means of installment payments or on credit,
Consultant shall not be reimbursed for such expenses until he had actually paid them, i.e., his account has been debited for each
installment. Consultant hereby acknowledges that once reimbursement has been received for goods purchased by Consultant on behalf
of the Company, such goods shall become the sole property of the Company.



 


		2.5	The payments provided by this Agreement shall be made to the Consultant after deduction of all
taxes and deductions at source required by applicable law.



 


		2.6	The parties hereto agree that all taxes, including but not limited to social insurance payments,
pension payments, health insurance and any other such payments, if existing, shall be borne solely by the Consultant. The Company
shall not pay nor be liable to pay any taxes upon the payment to the Consultant of any compensation as set forth in this Agreement.
Consultant hereby undertakes to indemnify and reimburse the Company for any amounts claimed or levied on the Company due to taxes,
social insurance payments, pension payments, health insurance and any other such payments resulting from any payment made by the
Company to the Consultant under this Agreement.



 




    	 



    	 



    

 


		2.7	The Company shall not undertake any social insurance premiums, pension payment and health insurance
on the name of the Consultant.



 


		2.8	The Consultant shall purchase, at his own expense, sufficient insurance policy covering the events
of illness, injuries and/or damages incurred by him in connection of his rendering of the Services to the Company.



 


		3	INDEPENDENT CONTRACTOR



 


		3.1	The Consultant warrants that he is aware that this Agreement is an agreement for the provision
of consulting services only, does not create employer-employee relations between him and the Company and does not confer upon him
any rights save for those set forth herein.



 


		3.2	The Consultant is not deemed to be an agent or a representative of the Company and therefore does
not possess any authority, whether actual or apparent, to represent the Company or to contractually commit the Company in any way
or manner, unless approved to do so in writing and in advance by the Company.



 


		3.3	Without prejudice to the generality of the foregoing, it is hereby agreed that the Consultant shall
not be entitled to receive from the Company severance pay or any other payment or consideration deriving from employee-employer
relations and/or the termination thereof, including, but not limited to, social benefits, managers' insurance fund, education fund,
or the like. The Consultant further undertakes that he shall not bring a claim against the Company with any cause of action based
on employee-employer relations between him and the Company, and undertakes to indemnify the Company, upon its first demand, for
all reasonable expenses that may be occasioned to it in respect of or in connection with any claim in connection with such employee-employer
relations. The Consultant declares that the Consulting Fee is 30% higher than the salary that he would have received should he
has been employed as an employee of the Company.



 


		3.4	If, for any reason whatsoever, any competent authority, including a judicial entity, determines
that the Consultant is to be regarded as an employee of the Company, or entitled to any amounts that are derived from employee-employer
relationships, then in lieu of the Consulting Fee that was paid to the Consultant by the Company as of the February 3, 2013, the
Consultant shall be deemed to be entitled to a reduced consideration which equals to 70% of the Consulting Fee (the “Reduced
Compensation”). The Consultant's entitlement to the Reduced Compensation shall be regarded as gross compensation and
shall apply retroactively as of February 3, 2013, and the Consultant shall immediately refund to the Company any amount paid on
account of the Consulting Fee by the Company as of February 3, 2013in excess of the Reduced Compensation.



 


		4	NONDISCLOSURE AND COMPETITIVE ACTIVITY



 


		4.1	As a condition to Consultant’s rights under this Agreement, Consultant will execute and deliver
to the Company the Secrecy, Non Competition and Proprietary Information agreement in the form attached hereto as Schedule
B. Consultant’s obligations under the said secrecy agreement will survive any termination of this Agreement.



 




    	 



    	 



    

 


		4.2	If Consultant breaches any or all of the covenants set forth in Schedule B hereto,
the Company shall be entitled to the following remedies: (i) damages from Consultant and (ii) in addition to its right to damages
and any other rights it may have, to obtain injunctive or other equitable relief to restrain any breach or threatened breach or
otherwise to specifically enforce the provisions of Schedule B attached hereto, it is agreed that money damages alone
would be inadequate to compensate the Company and would be an inadequate remedy for such breach.



 


		4.3	The rights and remedies of the parties to this Agreement are cumulative and not alternative.



 


		5	TERM AND TERMINATION



 


		5.1	The Term of the Agreement shall be a period of 12 months commencing on February 3, 2013.



 


		5.2	The Agreement shall be automatically renewed for consecutive periods of twelve (12) months (each
an "Additional Term"). In the Event that a Party provides written notice to the other Party two (2) months prior
to the expiry of the Initial Term or any Additional Term, as applicable, of its desire not to renew this Agreement, the Agreement
shall expire at the end of the Initial term or Additional term, as applicable (the Initial Term together with any Additional Term(s)
shall be referred to as the "Term of Agreement").



 


		5.3	Each Party shall be entitled to terminate this Agreement at any time upon a 60 days prior written
notice, without the obligation to provide any reason.



 


		5.4	Without prejudice to the provision of Sections 5.1 and 5.2 above:



 


		5.4.1	The Company shall have the right to terminate this Agreement (during the Initial Period and at
any time thereafter) for “just cause”, at any time, by giving the Consultant notice of termination for the just cause,
stating the reasons constituting the just cause. In such event, this Agreement shall be terminated within ten (10) days from the
time of delivery of the said notice. Any of the following actions or omissions by the Consultant shall constitute a "just
cause" under this Section 5.4.1: (i) a breach by Consultant of any of the covenants set forth in Schedule B
attached hereto; (ii) a material breach by Consultant of any provision of this Agreement other than Schedule B attached
hereto which is not cured by Consultant within five (5) days after his receipt of notice thereof from the Company containing a
description of the breach or breaches alleged to have occurred; (iii) habitual neglect by Consultant or gross failure by Consultant
to adequately perform his services and duties hereunder, or (iv) any act (or failure to act) of moral turpitude by Consultant or
action (or omission) by Consultant to harm the Company.



 


		5.4.2	The Consultant shall have the right to terminate this Agreement for “just cause”, at
any time, by giving to the Company notice of termination for the cause, stating specifically the reasons constituting the cause.
In such event, this Agreement shall be terminated as of the time of delivery of the said notice. Any of the following actions or
omissions by the Consultant shall constitute a "just cause" under this Section 5.4.2: (i) any action by the Company to
intentionally harm Consultant, or (ii) the Company becoming bankrupt or insolvent or ceasing or threatening to cease to carry on
business or being unable to pay its debts as they fall due or a receiver or other encumbrances being appointed to the undertaking
and assets, or any material part thereof of the Company.



 




    	 



    	 



    

 


		5.5	Upon termination of this Agreement, the Consultant shall be entitled to receive the Consulting
Fee accrued but unpaid (together with any expenses payable to Consultant pursuant to Section 2.4 above) as of the date of termination.
The Company shall be entitled to deduct and offset any amount owed by the Consultant to the Company, including but not limited,
to equipment and property belonging to the Company and not returned by the Consultant, from the payments made by the Company to
the Consultant upon such termination.



 


		5.6	Following notice of termination by any Party for any reason, other than upon termination by Consultant
for “just cause”, to the extent requested by the Company, the Consultant shall cooperate with the Company and use his
best efforts to assist the integration into the Company's organization of the person or persons who will assume the Consultant's
responsibilities hereunder. At the sole discretion of the Company, the Consultant shall during such period either continue the
rendering of the Consulting Services or cease such service.



 


		5.7	In the event of any termination of this Agreement, whether or not for "just cause" and
whatever the reason, the Consultant will promptly deliver to the Company all documents, data, records and other information pertaining
to the Consulting Services provided by it and any other equipment belonging to the Company in the Consultant’s possession,
and the Consultant will not take with him any documents or data, or any reproduction or excerpt of any documents or data, containing
or pertaining to the Consulting Services provided by it to the Company.



 


		6	REPRESENTATIONS BY THE CONSULTANT



 


			The Consultant hereby undertakes, represents and warrants as follows:



 


		6.1	There is no limitation and/or restriction in any agreement to which he is party, or by which he
is bound, on his ability to enter into this Agreement and/or to enter into a business relationship with the Company in accordance
with the provisions of this Agreement (including, without limitation, in any prior employment and/or consulting agreement entered
into by Consultant).



 


		6.2	The Consultant will exercise reasonable care and diligence to prevent, and will not take, any action
which could result in a conflict with, or be prejudicial to, the interests of the Company.



 


		6.3	Unless specifically authorized by the Designee, the Consultant is not granted and shall not exercise
the right or authority to assume or create any obligation or responsibility on behalf of or in the name of the Company, including
without limitation, contractual obligations and obligations based on warranties or guarantees.



 


		6.4	Consultant shall not, during the Term of Agreement and at any time thereafter, contact or communicate
any of the Companies employees, consultants, advisors, officers or any other personnel of the Company, without the prior written
consent of the Designee. Any contact or communication by Consultant shall only be made through Designee.



 




    	 



    	 



    

 


		7	MISCELLANEOUS



 


		7.1	This Agreement shall be subject to the laws of the state of Israel, excluding its conflict of law
provisions, and the competent courts of the Tel-Aviv District, Israel shall have exclusive jurisdiction over any dispute arising
there-from.



 


		7.2	This Agreement is the entire agreement between the parties with respect to the subject matter hereof,
and supersedes all prior understandings, agreements and discussions between them, either written or oral, with respect to such
subject matter.



 


		7.3	No alteration of or modification to any of the provisions of this Agreement shall be valid unless
made in writing and signed by both parties.



 


		7.4	The failure of either Party hereto to enforce at any time or for any period any provision of this
Agreement shall not be construed as a waiver of such right or provision and such party shall be entitled to enforce such right
or provision at any time as it shall see fit.



 


		7.5	Any notice required or permitted thereunder shall be given in writing and shall be deemed given
if sent by facsimile transmission or registered airmail to the address of the party.



 


		7.6	This Agreement may not be assigned without the written consent of the other party.



 


IN WITNESS WHEREOF, the parties hereto
have executed this Agreement as of the day and year first above written.


 


	InterCure Ltd. 	 	Consultant: 
	 	 	 
	By:	/s/ Ronen Twito	 	Signature: 	/s/ Reuven Zimlichman
	 	 	 	
	Name and Title:  Ronen Twito, CEO	 	Name: Prof. Reuven Zimlichman
	 	 	
	Date:  March 21 ,2013	 	Date:   March 21 ,2013


 




    	 



    	 



    

 


SCHEDULE A


 


The Consulting Services


 


Consultant shall provide the Company with the following consulting
services relating to Consultant's area of expertise:


 


		1.	Manage the clinical, regulatory and patent aspects of the Company's.






		2.	Advise and consult on new medical technologies.






		3.	Research and development






		4.	Manage the regulatory affairs of the company






		5.	Engage in extending the scope of the patents of the Company including extension of the term of the Companies patents.



 




    	 



    	 



    

 


SCHEDULE B


 


SECRECY,
NON-COMPETITION AND PROPRIETARY INFORMATION AGREEMENT


 


This Secrecy, Non-Competition and Proprietary
Information Agreement (the “Agreement”) is made as of March 21, 2013 by and between InterCure Ltd., an
Israeli publicly traded Company, with its principal offices at 16 Hatidhar St. P.O. Box 4131 Raanana, 43665, Israel, Israel (the
"Company") and Prof. Reuven Zimlichman, I.D. number 60592334
of 53 David Hamelech Str. Herzlia, 46661 Herzliya, Israel (“Consultant”).


 


WHEREAS   the
Consultant has entered an Consulting Agreement with the Company (the “Consulting Agreement”); and


 


WHEREAS   the Consultant
agreed to enter into this Undertaking;


 


NOW, THEREFORE, the Consultant undertakes
and warrants towards the Company and any subsidiary and parent company of the Company as follows: 


 


		1.	Confidential
Information



 


		1.1	In the course of providing services to the Company hereunder, the Consultant may have access to,
and become familiar with, “Confidential Information” of the Company (as hereinafter defined). The Consultant shall
at all times hereinafter maintain in the strictest confidence all such Confidential Information and shall not divulge any Confidential
Information to any person, firm or corporation without the prior written consent of the Company. For purposes hereof, “Confidential
Information” shall mean all information in any and all medium which is confidential by its nature, including, without
limitation, data, technology, know-how, inventions, ideas, discoveries, designs, processes, formulations, samples, compositions,
methods, models, and/or trade and business secrets relating to any line of business in which the Company is involved. Confidential
Information will also include the Company’s development, marketing and business plans relating to current, planned, old or
future products.



 


		1.2	The Consultant shall not use Confidential Information for, or in connection with, the development,
manufacture or the use of any product or for any other purpose whatsoever except as and to the extent provided in this Agreement
or in any other subsequent agreement between the parties.



 


		1.3	Notwithstanding the foregoing, Confidential Information shall not include information which the
Consultant can evidence to the Company by appropriate documentation: (i) is in, or enters the public domain otherwise than by reason
of a breach hereof by the Consultant; (ii) is known by the Consultant at the time of disclosure thereof by the Company; (iii) is
independently developed by the Consultant without recourse to Confidential Information; or (iv) is rightfully transmitted or disclosed
to the Consultant by a third party which owes an obligation of confidentiality with respect to such information.



 


		1.4	All Confidential Information made available to, or received by, the Consultant shall remain the
property of the company, and no license or other rights in or to the Confidential Information is granted hereby, the obligation
of the Consultant is not to use any Confidential Information disclosed pursuant to this Agreement except as provided in this Agreement,
shall remain in effect indefinitely, and the Consultant shall be prohibited from disclosing any such Confidential Information during
the term of this Agreement thereafter.



 




    	 



    	 



    

 


		1.5	All files, records, documents, drawings, specifications, equipment and similar items relating to
the business of the Company, whether prepared by the Consultant or otherwise coming into his possession, and whether classified
as Confidential Information or not, shall remain the exclusive property of the Company. Upon termination or expiration of this
Agreement, or upon request by the Company, the Consultant shall promptly turn over to the Company all such files, records, reports
analysis, documents and other material of any kind concerning the Company, which the Consultant obtained, received or prepared
pursuant to this Agreement.



 


		1.6	Except with prior written authorization by the Board of Directors of the Company (“BOD”),
the Consultant agrees not to disclose or publish any of the Confidential Information or material of the Company, its clients, partners,
shareholders or suppliers, or any other party to whom the Company owes an obligation of confidence, at any time during or after
his engagement with the Company.



 


		1.7	The Consultant agrees, during his engagement with the Company, not to improperly use or disclose
any proprietary information or trade secrets of any former or concurrent employer or other person or entity and that he will not
bring onto the premises of the Company any unpublished document or proprietary information belonging to any such employer, person
or entity unless consented to in writing by such employer, person or entity.



 


		1.8	The Consultant recognizes that the Company has received and in the future will receive from third
parties their confidential or proprietary information subject to a duty on the Company's part to maintain the confidentiality of
such information and to use it only for certain limited purposes. The Consultant agrees to hold all such confidential or proprietary
information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary
in carrying out such Consultant's work for the Company consistent with the Company's agreement with such third party.



 


		2.	Non-Competition



 


		2.1	The Consultant shall not at any time during the term of this Agreement and (a) in the event that
the Consultant’s engagement with the Company is terminated by the Company, other than for “just cause” under
Section 5.4.1. of the Consulting Agreement - for six (6) months thereafter, or (b) in the event that the Consultant’s engagement
with the Company is terminated by the Consultant or by the Company for “just cause” under Section 5.4.1. of the Consulting
Agreement - for twelve (12) months thereafter; directly or indirectly, engage in (as owner, stockholder, partner, director, officer,
employee, consultant or otherwise, except as an investor in a corporation whose stock is publicly traded and in which he holds
less than 5% of the outstanding shares) any business in the Field.



 


		2.2	Notwithstanding the aforesaid, the Consultant may, at any time during the term of this Agreement,
continue to perform academic research related to the activities and business of the Company, provided that any such academic research
shall not result in any way in a breach of any term of this Agreement and shall not be for any commercial activity.



 


		2.2	The Consultant shall not, directly or indirectly, either for himself or for the benefit of any
other Person or entity, at any time during the term of this Agreement and for Twelve (12) months thereafter, (A) induce or
attempt to induce any employee of the Company to leave the employ of the Company, (B) in any way interfere with the relationship
between the Company and any employee of the Company, (C) employ, or otherwise engage as an employee, independent contractor,
or otherwise, any employee of the Company, or (D) solicit any employee, customer, or supplier of the Company to cease or change
its legal or business relationship with the Company.



 




    	 



    	 



    

 


		2.3	In the event of a breach by the Consultant of any covenant set forth in Section 6 of this
Agreement, the term of such covenant will be extended by the period of the duration of such breach.



 


		3.	INVENTIONS.



 


		3.1	The Consultant has attached hereto, as Exhibit A, a list describing all inventions,
original works of authorship, developments, improvements, and trade secrets which were made by the Consultant prior to his engagement
with the Company (collectively referred to as "Prior Inventions"), which belong to the Consultant, which relate
to the Company's proposed business, products or research and development, and which are not assigned to the Company
hereunder; or, if no such list is attached, the Consultant represents that there are no such Prior Inventions. If in the course
of this Agreement with the Company, the Consultant incorporates into a product, process or machine of the Company, a Prior Invention
owned by the Consultant or in which the Consultant has an interest, the Company is hereby granted and shall have a non-exclusive,
royalty-free, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention as part of
or in connection with such product, process or machine.



 


		3.2	The Consultant will disclose and deliver to the Company for the exclusive use and benefit of the
Company any Inventions (which in this paragraph shall mean any discovery, technique, design, formula, method of manufacture, inventions,
secret process, improvements, and modifications (whether or not capable of protection by rights in the nature of intellectual property)
which the Consultant alone or with one or more others has made or discovered during the Term of this Agreement and which pertain
to or result from any work which the Consultant has done or may hereafter do for the Company), promptly upon the making, devising,
or discovering of the same, and will give all information and data in his possession as to the exact mode of working, producing,
and using the same and also all such explanations and instructions as may in the view of the Company be necessary to enable the
full and effectual working, production, or use of the same and will at the expense of the Company furnish it with all necessary
plans, drawings, formulae, and models.



 


		3.3	The Consultant, during the term of this Agreement, will without charge to but at the expense of
the Company execute and do all acts, matters, documents, and things to enable the Company or its nominee to apply for and obtain
protection for the Inventions in any or all countries and to vest title in the Company or such nominee absolutely.



 


		3.4	The Consultant hereby irrevocably appoints the Company to be his attorney in his name and on his
behalf to execute and do such acts, matters, documents, and things as aforesaid and generally to use his name for the purpose of
giving to the Company (or its nominee) the full benefit of the provisions of this section. In favor of any third party a certificate
signed by any director or the secretary of the Company that an instrument or act falls within the authority hereby conferred shall
be conclusive evidence that such is the case.



 


		3.5	During the term of this Agreement and at all times thereafter the Consultant will (whether by omission
or commission) do nothing to affect or imperil the validity of the protection for the Inventions obtained or applied for by the
Company or its nominee pursuant to this paragraph. The Consultant will at the direction and expense of the Company render all assistance
within his power to obtain and maintain such protection or application or any extension thereof.



 




    	 



    	 



    

 


		3.6	Nothing in this Agreement shall oblige the Company to seek patent or other protection for any Invention
nor to exploit any Invention.



 


		3.7	The Consultant shall promptly disclose to the Company all copyright works or designs originated,
conceived, written, or made by him alone or with others (except only those works originated, conceived, written, or made by him
prior to being engaged by the Company or on his own time and not derived from or related to the work done by him to the Company)
and shall, until such rights shall be fully and absolutely vested in the Company, hold them in trust for the Company.



 


		3.8	The Consultant hereby assigns to the Company by way of future assignment all copyright, design
right, and other proprietary rights, if any, for the full terms thereof throughout the world in respect of all copyright works
and designs originated, conceived, written, or made by the Consultant (except only those works or designs originated, conceived,
written, or made by the Consultant wholly outside his normal working hours with the Company and wholly unconnected with the services
he renders to the Company) during the period of his Agreement hereunder and during all previous periods of engagement with the
Company engagement.



 


		3.9	The Consultant will, at the request and expense of the Company, do all things necessary or desirable
to substantiate the rights of the Company under Section 3.8, and hereby acknowledges and agrees that the provisions of this
paragraph shall survive any termination of this Agreement.



 


		3.10	For the removal of any doubt, it is hereby clarified that the provisions contained in Sections 3.2
and 3.8 above will apply also to any "Service Inventions" as defined in the Israeli Patent Law, 1967 (the "Patent
Law"). However, in no event will such Service Invention become the property of the Consultant and the provisions contained
in Section 132(b) of the Patent Law shall not apply unless the Company provides in writing otherwise. The Consultant will
not be entitled to royalties or other payment with regard to any Prior Inventions, Service Inventions or any of the intellectual
property rights set forth above, including any commercialization of such Prior Inventions, Service Inventions or other intellectual
property rights.



 


		3.11	In the event that following the termination of his Agreement with the Company, the Consultant is
requested to assist the Company on any matter related to this Section 3, the Company will be required to pay the Consultant the
standard fee the Consultant may charge at that time for consulting or advising other third parties as remuneration for the Consultant’s
efforts hereunder.



 


IN WITNESS WHEREOF, the parties hereto have executed this Secrecy,
Non-Competition and Proprietary Information Undertaking as of the day and year first above written.


 


	InterCure Ltd.	 	Prof. Reuven Zimlichman
	 	 	 
	By: Ronen Twito, CEO	 	
	 	 	 
	Signature: 	/s/ Ronen Twito	 	Signature: 	/s/ Reuven Zimlichman


 




    	 



    	 



    

 


Exhibit A 


 


to the SECRECY, NON-COMPETITION AND
PROPRIETARY INFORMATION AGREEMENT


 


List of Prior Inventions